Q1 2025 13F Holders as of 3/31/2025
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
18.5M
-
Number of holders
-
87
-
Total 13F shares, excl. options
-
11.7M
-
Shares change
-
+386K
-
Total reported value, excl. options
-
$102M
-
Value change
-
+$5.71M
-
Put/Call ratio
-
2.08
-
Number of buys
-
42
-
Number of sells
-
-43
-
Price
-
$8.66
Significant Holders of OptimizeRx Corp - Common Stock (OPRX) as of Q1 2025
110 filings reported holding OPRX - OptimizeRx Corp - Common Stock as of Q1 2025.
OptimizeRx Corp - Common Stock (OPRX) has 87 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 11.7M shares
of 18.5M outstanding shares and own 63.38% of the company stock.
Largest 10 shareholders include Whetstone Capital Advisors, LLC (1.51M shares), BlackRock, Inc. (1.32M shares), ROYCE & ASSOCIATES LP (994K shares), VANGUARD GROUP INC (922K shares), BLAIR WILLIAM & CO/IL (631K shares), RICE HALL JAMES & ASSOCIATES, LLC (576K shares), KENNEDY CAPITAL MANAGEMENT LLC (478K shares), Parkman Healthcare Partners LLC (475K shares), DIMENSIONAL FUND ADVISORS LP (432K shares), and GEODE CAPITAL MANAGEMENT, LLC (408K shares).
This table shows the top 87 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.